NUVL
Nuvalent, Inc.
NASDAQ · Healthcare · Biotechnology · US
$123.96
+0.00%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.14x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 0.48x
Liquidity & coverage
- Current ratio
- 16.14x
- Quick ratio
- 16.14x
- Cash ratio
- 15.88x
- Interest coverage
- -34.11x
- EBITDA / interest
- -25.99x
- Working capital
- $1.2B
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026